OVERVIEW

14th Annual Updates in the Treatment and Management of Hematologic Malignancies is organized by HCA Healthcare and will be held on Feb 06, 2025 at Empower Field at Mile High, Denver, Colorado, United States of America.

Description:
The 14th Annual Updates in the Treatment and Management of Hematologic Malignancies Highlights from San Diego provides an invaluable educational experience highlighting the latest advances in malignant and non-malignant hematology. Please join us and engage with experts to learn and gain practical insights on current therapies, and innovative treatments. Available on-demand, this activity ensures that health care professionals caring for these patients have unlimited access to the latest scientific updates, innovative ideas, and pressing issues in their field. Participants can gain valuable insights ultimately improving the care and outcomes of patients with hematologic malignancies.

Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Participants will be able to identify appropriate therapeutic strategies based on the most current evidence, ensuring optimal patient selection for novel treatments in lymphoma, leukemia, and multiple myeloma.
  • Demonstrate an improved ability to anticipate, recognize, and manage toxicities related to therapies, leading to enhanced patient safety and better clinical outcomes.
  • Analyze the latest clinical trial data and FDA- approved therapies for the treatment of hematologic malignancies, including CAR-T therapy, bispecific antibodies, and small-molecule inhibitors.

KEY DATES

Event Start Date
06 Feb, 2025
Event Start Date
Event End Date
06 Feb, 2025
Event End Date
Credits

Accreditation:

American Board of Internal Medicine (ABIM):
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Available Credit:
3.00 AMA PRA Category 1 Credit™
HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

HCA Healthcare Continental Division designates this for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
3.00 Attendance

  • 3 AMA PRA Category 1 Credits™
  • 3 MOC
  • TARGET AUDIENCE

    PhysicianOncologistsHematologistAdvanced Practice Providers

    SPECIALITIES

    HematologyOncology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationEmpower Field at Mile High
    1701 Bryant St

    RELATED CONFERENCES & LIVE WEBINARS

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Oncology
    30 CME
    ...
    More actions
    GB£19

    Feb 01 - 02, 2027 | Dubai, Dubai, UAE

    Pathology
    30 CME
    ...
    More actions
    GB£45